You are here

  • Home
  • Archive
  • Volume 80, Issue 12
  • Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System

Article metrics

Article menu
Letter
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System

 

Online download statistics by month:

Online download statistics by month: July 2021 to March 2024

AbstractFullPdf
Jul 2021378374134
Aug 202142141683
Sep 202119519126
Oct 202111111028
Nov 202148147681
Dec 202157957254
Jan 202217317128
Feb 2022797521
Mar 2022726716
Apr 2022746713
May 2022666427
Jun 2022535113
Jul 202250499
Aug 2022504913
Sep 2022666519
Oct 2022535021
Nov 202242417
Dec 2022535318
Jan 2023494825
Feb 2023848010
Mar 202366645
Apr 2023292913
May 2023353515
Jun 202328283
Jul 2023433912
Aug 2023312810
Sep 202328284
Oct 202336323
Nov 202330302
Dec 2023404014
Jan 202418189
Feb 202425184
Mar 2024252460
Total35633482800